Stryker Corporation $SYK Holdings Boosted by Retirement Guys Formula LLC

Retirement Guys Formula LLC boosted its position in shares of Stryker Corporation (NYSE:SYK) by 5.6% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 4,102 shares of the medical technology company’s stock after purchasing an additional 218 shares during the period. Retirement Guys Formula LLC’s holdings in Stryker were worth $1,623,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SYK. Brighton Jones LLC grew its holdings in shares of Stryker by 15.4% during the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after acquiring an additional 609 shares in the last quarter. Park Square Financial Group LLC purchased a new position in shares of Stryker during the 4th quarter valued at $67,000. Wood Tarver Financial Group LLC purchased a new position in shares of Stryker during the 4th quarter valued at $71,000. Centaurus Financial Inc. grew its holdings in shares of Stryker by 16.8% during the 4th quarter. Centaurus Financial Inc. now owns 1,246 shares of the medical technology company’s stock valued at $449,000 after acquiring an additional 179 shares in the last quarter. Finally, PKO Investment Management Joint Stock Co purchased a new position in shares of Stryker during the 4th quarter valued at $1,080,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, insider Viju Menon sold 500 shares of the business’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the transaction, the insider owned 12,511 shares in the company, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction dated Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the transaction, the director owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their position. The disclosure for this sale can be found here. Insiders own 5.90% of the company’s stock.

Stryker Stock Down 0.7%

Stryker stock opened at $370.92 on Thursday. The firm has a market cap of $141.81 billion, a price-to-earnings ratio of 49.13, a P/E/G ratio of 2.69 and a beta of 0.93. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The firm has a fifty day moving average price of $386.51 and a two-hundred day moving average price of $378.95.

Stryker (NYSE:SYK) last released its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share for the quarter, topping analysts’ consensus estimates of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The business’s revenue was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, analysts forecast that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s payout ratio is presently 44.50%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on SYK shares. Wells Fargo & Company boosted their price target on shares of Stryker from $435.00 to $445.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Truist Financial set a $415.00 price target on shares of Stryker and gave the company a “hold” rating in a report on Monday, August 4th. Rothschild Redb raised shares of Stryker to a “hold” rating in a research note on Thursday, September 18th. Wall Street Zen raised shares of Stryker from a “hold” rating to a “buy” rating in a research note on Friday, July 18th. Finally, Needham & Company LLC lifted their price objective on shares of Stryker from $442.00 to $448.00 and gave the company a “buy” rating in a research note on Friday, August 1st. Fourteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $430.33.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.